NCT02137798View on ClinicalTrials.gov

Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Atrial Fibrillation
Interventions
DEVICE

Radio-frequency catheter ablation

Radio-frequency atrial fibrillation catheter ablation includes circumferential PV isolation and voltage-map guided substrate modification, which means low voltage zone (amplitude \< o.5 mV) will also be ablated.

Trial Locations (1)

01307

Department of Electrophysiology, University of Dresden - Heart Center, Dresden

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Technische Universität Dresden

OTHER

NCT02137798 - Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter